Ethical Challenges of Allocating Vaccines in a Pandemic - By Manisha Kukreti

The year 2021 brings a sense of hope to Indians with India's drugs regulator, Drugs Controller General of India, approving emergency use authorization of Oxford COVID-19 vaccine Covishield, locally manufactured by Serum Institute of India and Bharat Biotech's indigenously manufactured Covaxin. However, a streak of uncertainty is also looming large with the explosion of a new mutation of the corona virus in UK, now spreading fast across the world.

  • Health Ministry has recently released a guideline for COVID-19 vaccine stating that it will be offered first to healthcare workers, frontline workers and to persons above 50, followed by persons younger than ....
Do You Want to Read More?
Subscribe Now

To get access to detailed content

Already a Member? Login here


Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.